Nuvectis Pharma, Inc. Loss Contingency Accrual, Provision
Nuvectis Pharma, Inc. (NVCT) reported Loss Contingency Accrual, Provision of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Loss Contingency › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualProvision · last filed 2026-05-05
- Nuvectis Pharma, Inc. loss contingency accrual, provision for the quarter ending 2026-03-31 was $0.00.
- Nuvectis Pharma, Inc. loss contingency accrual, provision for the quarter ending 2025-12-31 was $0.00.
- Nuvectis Pharma, Inc. loss contingency accrual, provision for the quarter ending 2025-09-30 was $0.00.
- Nuvectis Pharma, Inc. loss contingency accrual, provision for the quarter ending 2025-06-30 was $0.00.
| Period end | Loss Contingency Accrual, Provision 3 month | Loss Contingency Accrual, Provision 6 month | Loss Contingency Accrual, Provision 9 month | Loss Contingency Accrual, Provision 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 10-Q · filed 2026-05-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 derived: sum of 3 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 derived: sum of 3 quarters · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 derived: sum of 3 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |